𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suppressor cell activity in melanoma patients. I. Relation to tumor growth and immunoglobulin levels in vivo

✍ Scribed by J. Werkmeister; W. McCarthy; P. Hersey

Book ID
102867062
Publisher
John Wiley and Sons
Year
1981
Tongue
French
Weight
725 KB
Volume
28
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The effect of tumor growth on the suppressor cell activity of melanoma patients was examined by measurement of immunoglobulin produced in vitro in pokeweed mitogen (PWM)‐stimulated cultures of B and T lymphocytes. B and T cells were separated by sheep red blood cell resetting and suppressor cell activity was assessed by comparison of immunoglobulins produced in cultures with irradiated T cells (2,000 rads) to that with unirradiated T cells. In the majority of patients with localized melanoma, radiosensitive suppressor T cells were detected and appeared to be an augmentation of a normal physiological state. In patients with Stage I and II melanoma, removal of the tumor resulted in a significant decrease in suppressor activity against IgA and IgM but not against IgG production. Similar sequential changes in suppressor cell activity were not generally detected in patients who had surgery for skin graft after previous removal of the primary melanoma or in patients undergoing surgery for non‐malignant conditions. Sequential studies on the levels of serum immunoglobulins showed an apparent trend for immunoglobulins to increase after surgery. Of particular importance, the decrease in in vitro suppressor cell activity against IgM and IgG production after tumor removal in individual patients was significantly associated with an increase in immunoglobulin levels in the serum of these patients. It is suggested that these findings may account in part for the absence of detectable antibody responses to melanoma antigens in many patients and for the generalized immunodeficiency in patients with disseminated melanoma.

📜 SIMILAR VOLUMES

Suppressor cell activity in melanoma pat
Suppressor cell activity in melanoma patients. II. Concanavalin A-induced suppressor cells in relation to tumor growth and suppressor T-cell subsets
✍ J. Werkmeister; Georgina Phillips; W. McCarthy; P. Hersey 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 French ⚖ 487 KB 👁 1 views

## Abstract The relative proportions of T, B and Tγ suppressor cells were determined sequentially in peripheral blood of melanoma patients before and after surgery. Concanavalin A (Con A)‐induced suppression against lymphocyte mitogenesis of melanoma patients and age‐matched controls was measured c

Sequential studies on cell-mediated tumo
Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma
✍ I. Hellström; G. A. Warner; K. E. Hellström; H. O. Sjögren 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 French ⚖ 920 KB

## Abstract Ten human patients with malignant melanoma were followed with respect to two __in vitro__ parameters of tumor immunity, the ability of the patients' blood lymphocytes to destroy cultivated melanoma cells, and the ability of the patients' sera to block such destruction, and with respect

The lack of correlation between experime
The lack of correlation between experimental metastatic potential and platelet aggregating activity of B16 melanoma clones viewed in relation to tumor cell heterogeneity
✍ Arthur K. Kimura; Paulette Mehta; Jianhua Xiang; Daniel Lawson; Donald Dugger; K 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 514 KB

Two widely used B16 melanoma cell lines of low and high lung colonizing potential (B16-F1 and B16-F10) were compared in their ability to induce platelet aggregation. The results of these experiments showed a reproducible difference in platelet aggregating activity of these two cell lines which direc

Selective antibody-mediated targeting of
Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo
✍ Hila Novak; Roy Noy; Kfir Oved; Dina Segal; Winfried S. Wels; Yoram Reiter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB 👁 1 views

## Abstract Epidermal growth factor receptor (EGFR) is highly overexpressed in many tumor types. We present a new fusion molecule that can target solid tumors that express EGFR. The fusion molecule combines the advantage(s) of the well‐established tumor targeting capabilities of high affinity recom